Please use this identifier to cite or link to this item:
Title: Xenofree generation of limbal stem cells for ocular surface advanced cell therapy.
Author: Nieto-Nicolau, Nuria
Martínez-Conesa, Eva M.
Velasco-García, Alba M.
Aloy-Reverté, Caterina
Vilarrodona, Anna
Caasaroli Marano, Ricardo Pedro
Keywords: Cèl·lules mare
Stem cells
Issue Date: 4-Dec-2019
Publisher: BioMed Central
Abstract: Background: Limbal stem cells (LSC) sustain the corneal integrity and homeostasis. LSC deficiency (LSCD) leads to loss of corneal transparency and blindness. A clinical approach to treat unilateral LSCD comprises autologous cultured limbal epithelial stem cell transplantation (CLET). CLET uses xenobiotic culture systems with potential zoonotic transmission risks, and regulatory guidelines make necessary to find xenofree alternatives. Methods: We compared two xenofree clinical grade media and two feeder layers. We used CnT07, a defined commercial medium for keratinocytes, and a modified xenofree supplemented hormonal epithelial medium with human serum (XSHEM). Optimal formulation was used to compare two feeder layers: the gold standard 3T3 murine fibroblasts and human processed lipoaspirate cells (PLA). We tested the expressions of ΔNp63α and cytokeratin 3 and 12 by qPCR and immunofluorescence. Morphology, viability, clonogenicity, proliferation, and cell growth assays were carried out. We also evaluated interleukin 6 (IL-6) and stromal-derived factor 1 (SDF-1) by qPCR and ELISA. Results: XSHEM maintained better LSC culture viability and morphology than CnT07. Irradiated PLA feeder cells improved the undifferentiated state of LSC and enhanced their growth and clonogenicity stimulating IL-6 secretion and SDF-1 expression, as well as increased proliferation and cell growth when compared with irradiated 3T3 feeder cells. Conclusions: The combination of XSHEM and PLA feeder cells efficiently sustained LSC xenofree cultures for clinical application. Moreover, PLA feeder layers were able to improve the LSC potential characteristics. Our results would have direct clinical application in CLET for advanced therapy.
Note: Reproducció del document publicat a:
It is part of: Stem Cell Research & Therapy, 2019, vol. 10, p. 374
Related resource:
ISSN: 1757-6512
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
696974.pdf2.45 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons